
Immunic Inc
NASDAQ:IMUX

Intrinsic Value
The intrinsic value of one
IMUX
stock under the Base Case scenario is
9.18
USD.
Compared to the current market price of 0.72 USD,
Immunic Inc
is
Undervalued by 92%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Fundamental Analysis


Revenue & Expenses Breakdown
Immunic Inc
Balance Sheet Decomposition
Immunic Inc
Current Assets | 19m |
Cash & Short-Term Investments | 14.3m |
Receivables | 631k |
Other Current Assets | 4m |
Non-Current Assets | 1.5m |
PP&E | 1.5m |
Free Cash Flow Analysis
Immunic Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Immunic Inc
Revenue
|
0
USD
|
Operating Expenses
|
-101m
USD
|
Operating Income
|
-101m
USD
|
Other Expenses
|
4.6m
USD
|
Net Income
|
-96.4m
USD
|
IMUX Profitability Score
Profitability Due Diligence
Immunic Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Score
Immunic Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
IMUX Solvency Score
Solvency Due Diligence
Immunic Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Score
Immunic Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IMUX Price Targets Summary
Immunic Inc
Dividends
Current shareholder yield for IMUX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?